Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 146,081Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Cancidas

PharmaCompass

01

Brand Name : Cancidas

Caspofungin

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Cancidas

arrow
Medlab Asia & Asia Health
Not Confirmed

Caspofungin

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 214

2019 Revenue in Millions : 249

Growth (%) : -14

blank

02

Brand Name : Cancidas

Caspofungin

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Cancidas

arrow
Medlab Asia & Asia Health
Not Confirmed

Caspofungin

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 212

2020 Revenue in Millions : 213

Growth (%) : 0

blank

03

Brand Name : Cancidas

Caspofungin

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Cancidas

arrow
Medlab Asia & Asia Health
Not Confirmed

Caspofungin

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2022 Revenue in Millions : 174

2021 Revenue in Millions : 212

Growth (%) : -18

blank

04

Brand Name : Cancidas

Caspofungin Acetate

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Cancidas

arrow
Medlab Asia & Asia Health
Not Confirmed

Caspofungin Acetate

Main Therapeutic Indication : Anti-fungal

Currency : USD

2015 Revenue in Millions : 681

2014 Revenue in Millions : 573

Growth (%) : -16%

blank

05

Brand Name : Cancidas

Caspofungin Acetate

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Cancidas

arrow
Medlab Asia & Asia Health
Not Confirmed

Caspofungin Acetate

Main Therapeutic Indication : Anti-fungal

Currency : USD

2014 Revenue in Millions : 3.20%

2013 Revenue in Millions :

Growth (%) :

blank

06

Brand Name : Cancidas

Caspofungin Acetate

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Cancidas

arrow
Medlab Asia & Asia Health
Not Confirmed

Caspofungin Acetate

Main Therapeutic Indication : Anti-Fungal

Currency : USD

2016 Revenue in Millions : 558

2015 Revenue in Millions : 572

Growth (%) : -2

blank

07

Brand Name : Cancidas

Caspofungin Acetate

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Cancidas

arrow
Medlab Asia & Asia Health
Not Confirmed

Caspofungin Acetate

Main Therapeutic Indication : Anti-fungal

Currency : USD

2017 Revenue in Millions : 422

2016 Revenue in Millions : 558

Growth (%) : -24

blank

08

Brand Name : Cancidas

Caspofungin Acetate

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Cancidas

arrow
Medlab Asia & Asia Health
Not Confirmed

Caspofungin Acetate

Main Therapeutic Indication : Anti-Fungal

Currency : USD

2018 Revenue in Millions : 326

2017 Revenue in Millions : 422

Growth (%) : -23%

blank

09

Brand Name : Cancidas

Caspofungin

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Cancidas

arrow
Medlab Asia & Asia Health
Not Confirmed

Caspofungin

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2019 Revenue in Millions : 249

2018 Revenue in Millions : 326

Growth (%) : -24

blank